DDX58 and Classic Singleton-Merten Syndrome.
Adult
Aortic Diseases
/ genetics
Cell Line
DEAD Box Protein 58
/ genetics
Dental Enamel Hypoplasia
/ genetics
Female
Gain of Function Mutation
/ genetics
HEK293 Cells
Humans
Interferon Type I
/ genetics
Male
Metacarpus
/ abnormalities
Middle Aged
Muscular Diseases
/ genetics
Odontodysplasia
/ genetics
Osteoporosis
/ genetics
Phenotype
Promoter Regions, Genetic
/ genetics
Receptors, Immunologic
Vascular Calcification
/ genetics
Interferonopathy
Singleton-Merten syndrome
retinoic acid-inducible gene I
type I interferon
Journal
Journal of clinical immunology
ISSN: 1573-2592
Titre abrégé: J Clin Immunol
Pays: Netherlands
ID NLM: 8102137
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
received:
31
05
2018
accepted:
11
11
2018
pubmed:
24
12
2018
medline:
27
11
2019
entrez:
22
12
2018
Statut:
ppublish
Résumé
Singleton-Merten syndrome manifests as dental dysplasia, glaucoma, psoriasis, aortic calcification, and skeletal abnormalities including tendon rupture and arthropathy. Pathogenic variants in IFIH1 have previously been associated with the classic Singleton-Merten syndrome, while variants in DDX58 has been described in association with a milder phenotype, which is suggested to have a better prognosis. We studied a family with severe, "classic" Singleton-Merten syndrome. We undertook clinical phenotyping, next-generation sequencing, and functional studies of type I interferon production in patient whole blood and assessed the type I interferon promoter activity in HEK293 cells transfected with wild-type or mutant DDX58 stimulated with Poly I:C. We demonstrate a DDX58 autosomal dominant gain-of-function mutation, with constitutive upregulation of type I interferon. DDX58 mutations may be associated with the classic features of Singleton-Merten syndrome including dental dysplasia, tendon rupture, and severe cardiac sequela.
Identifiants
pubmed: 30574673
doi: 10.1007/s10875-018-0572-1
pii: 10.1007/s10875-018-0572-1
pmc: PMC6394545
doi:
Substances chimiques
Interferon Type I
0
Receptors, Immunologic
0
RIGI protein, human
EC 3.6.1.-
DEAD Box Protein 58
EC 3.6.4.13
Types de publication
Case Reports
Journal Article
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
75-80Subventions
Organisme : NIAID NIH HHS
ID : R01 AI106912
Pays : United States
Organisme : Department of Health
ID : TRF-2016-09-002
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : ZIA AI001220
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI111784
Pays : United States
Organisme : NIH HHS
ID : R01 OD010944
Pays : United States
Références
Cell. 2011 Oct 14;147(2):409-22
pubmed: 22000018
Br J Dermatol. 2015 Dec;173(6):1505-13
pubmed: 26284909
J Clin Invest. 2018 Jul 2;128(7):3041-3052
pubmed: 29649002
Am J Hum Genet. 2014 Jul 3;95(1):121-5
pubmed: 24995871
Am J Hum Genet. 2015 Feb 5;96(2):275-82
pubmed: 25620204
Am J Med Genet A. 2013 Feb;161A(2):360-70
pubmed: 23322711
J Allergy Clin Immunol. 2016 Dec;138(6):1752-1755
pubmed: 27554814
Nat Genet. 2014 May;46(5):503-509
pubmed: 24686847
Nature. 2014 May 1;509(7498):110-4
pubmed: 24590070
Neurology. 2018 Feb 6;90(6):289-291
pubmed: 29321238
J Interferon Cytokine Res. 2018 Apr;38(4):171-185
pubmed: 29638206
Am J Med Genet A. 2015 Feb;167A(2):296-312
pubmed: 25604658
Arthritis Rheumatol. 2017 Oct;69(10):2081-2091
pubmed: 28605144
Nature. 2011 Sep 25;479(7373):423-7
pubmed: 21947008
Nat Commun. 2017 Dec 19;8(1):2176
pubmed: 29259162
Am J Hum Genet. 2015 Feb 5;96(2):266-74
pubmed: 25620203